PT-141 10MG

$220.00

Full Name: Bremelanotide
Alternative Name: PT-141
CAS #: 189691-06-3
Molecular Formula: C₅₀H₆₈N₁₄O₁₀
Molecular Weight (M.W.): Approximately 1025.2 g/mol
Sequence: Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-OH
Length: 7 amino-acid residues
Product Type: Modified Cyclic Research Peptide

Category:

Description

PT-141, also known as Bremelanotide, is a modified cyclic peptide supplied for controlled laboratory, analytical, and scientific research.

Its molecular identity includes an N-terminal acetyl group, non-standard norleucine, D-phenylalanine, and a cyclic structure formed through an internal Asp-Lys lactam linkage. These structural features are essential for accurate analytical identification and distinguish PT-141 from conventional linear peptides.

For technical documentation, the exact salt or counter-ion form, purity specification, terminal state, and lot-specific analytical profile should be confirmed using the applicable Certificate of Analysis.

Research Applications

PT-141 may be examined in controlled non-clinical research involving:

  • Modified peptide characterization
  • Cyclic peptide analysis
  • Structure-function research
  • Ligand-receptor interaction studies
  • Molecular signaling research
  • Stereochemical characterization
  • Chromatographic profiling
  • Stability assessment
  • Non-clinical biochemical and cellular models

Experimental observations should remain specific to the applicable research system and should not be interpreted as evidence of behavioral, reproductive, therapeutic, or clinical effectiveness.

Structural Information

PT-141 is commonly represented as:

Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-OH

Key structural characteristics include:

  • Seven-residue peptide architecture
  • N-terminal acetylation
  • Norleucine residue
  • D-phenylalanine residue
  • Internal Asp-Lys lactam cyclization
  • Free C-terminal carboxyl group
  • Product-dependent counter-ion characteristics

Analytical Identification

Relevant analytical characterization may include:

  • Peptide identity confirmation
  • Molecular-mass assessment
  • Cyclic structure verification
  • Stereochemical characterization
  • N-terminal acetylation confirmation
  • Chromatographic purity testing
  • Counter-ion assessment
  • Lot-specific quality analysis

Specifications & Documentation

Lot-specific documentation should be reviewed for:

  • PT-141 identity
  • CAS number
  • Molecular formula
  • Molecular weight
  • Complete peptide structure
  • Cyclization state
  • Stereochemical configuration
  • Terminal modifications
  • Salt or counter-ion form
  • Purity specification
  • Analytical testing
  • Lot or batch information
  • Certificate of Analysis
  • Storage requirements

Authenticated product-specific documentation should take precedence over generalized reference values.

Storage & Handling

Store according to the conditions specified on the product label and Certificate of Analysis. Protect the material from environmental conditions that could compromise peptide integrity.

Follow established laboratory procedures appropriate for modified cyclic research peptides.

Research Use Only

PT-141 is supplied exclusively for laboratory research, analytical testing, and scientific reference purposes.

Disclaimer

For research use only. Not for human or veterinary use. Not intended for consumption, administration, behavioral use, reproductive use, diagnosis, treatment, mitigation, cure, or prevention of any disease. No therapeutic, behavioral, reproductive, medical, or clinical claims are made or implied. Product information is supplied solely for scientific identification, documentation, and research reference.

 

Reviews

There are no reviews yet.

Be the first to review “PT-141 10MG”

Your email address will not be published. Required fields are marked *